Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Moving more often is beneficial for long-term weight maintenance in older adults

When considered alongside the current Physical Activity Guidelines for Americans, new findings suggest that focusing less on structured exercise, and more on building frequent periods of enjoyable movement into the day, will more likely contribute to health benefits that can be sustained, according to a paper published online in Obesity, The Obesity Society's flagship journal.

21 Dec 2021

A new approach for drugs to be more effective against inflammatory bowel disease

Biomedical scientists at the University of California, Riverside, propose a way for drugs to be more effective against inflammatory bowel disease, or IBD, in which the intestine undergoes inflammation.

18 Dec 2021

Trial identifies a drug that may benefit some patients hospitalized with COVID-19 pneumonia

A proof-of-concept trial led by the Universities of Birmingham and University Hospitals Birmingham NHS Foundation Trust has identified a drug that may offer benefit some patients hospitalized with COVID-19 pneumonia.

18 Dec 2021

‘The charges seem crazy’: Hospitals impose a ‘facility fee’ — for a video visit

When Arielle Harrison's 9-year-old needed to see a pediatric specialist at Yale New Haven Health System in June, a telehealth visit seemed like a great option. Since her son wasn't yet eligible to be vaccinated against covid-19, they could connect with the doctor via video and avoid venturing into a germy medical facility.

17 Dec 2021

Combination of gallic acid and stretching decreases arthritis inflammation markers in the cells

A healthy diet and a little exercise appear to be good for arthritis, even on the cellular level.

15 Dec 2021

Colorado hospitals in ‘critical condition’ as state weathers another surge

Harold Burch's home has a spectacular view in Paonia, a rural part of Colorado's Western Slope at the foot of Mount Lamborn. But the landscape has been little consolation to the 60-year-old as he has battled a cascade of health problems during the pandemic.

15 Dec 2021

New drug combination may prevent GvHD after stem cell transplantation for blood cancers

A drug combination can safely prevent transplanted stem cells, known as a graft, from attacking the recipient's body, allowing them to develop into healthy new blood and immune cells, a new study shows.

14 Dec 2021

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Researchers from the Duke Molecular Physiology Institute have been investigating genetic associations with more severe disease and examining the associations that certain genetic features have with other diseases.

13 Dec 2021

Insight into immune cell communication may pave the way for new cancer vaccines

In the past decade, immunotherapy has helped save the lives of many cancer patients, many with lung cancer, who might have otherwise faced almost certain death sentences.

9 Dec 2021

New report provides data on the wellbeing of working-age Australians with chronic conditions

Chronic health conditions are the leading cause of poor health and mortality in Australia but they also have a major impact on other parts of people’s lives.

9 Dec 2021

Study identifies several proteins that protect against disease development

Inflammatory processes are associated with a large range of human diseases, including rheumatic diseases and allergies. Protein biomarkers are measurable molecules that can have a prognostic value in patients, be used to diagnose disease, or indicate severity of disease.

8 Dec 2021

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

Octapharma USA today announced the U.S. Food & Drug Administration has approved cutaquig [Immune globulin, Subcutaneous (Human)-hipp, 16.5% Solution] for the treatment of pediatric patients age 2 and older with primary humoral immunodeficiency (PI). The FDA previously approved cutaquig for adults with PI.

7 Dec 2021

NEI researchers identify unique population of B cells that tamps down the immune system

Researchers at the National Eye Institute (NEI) have identified, isolated, and characterized a unique population of B cells that tamps down the immune system, reducing chronic inflammation.

2 Dec 2021

Researchers identify new drug that makes pancreatic cancer cells more vulnerable to chemotherapy

Researchers at Washington University School of Medicine in St. Louis have identified a drug compound that makes pancreatic cancer cells more vulnerable to chemotherapy.

1 Dec 2021

Virginia Tech researchers discover potential target for diagnosing and treating Lyme disease

You don't have to go far to find ticks. Just step outside and look for some grass. Look to the top of the shiny, green blade – usually ankle high. A tick might be there, waiting.

30 Nov 2021

Irregular body clock plays key role in driving inflammation in the immune cells, research shows

New research from RCSI has demonstrated the significant role that an irregular body clock plays in driving inflammation in the body's immune cells, with implications for the most serious and prevalent diseases in humans.

24 Nov 2021

Minimally invasive ablation procedure offers long-term relief after knee replacement surgery

A minimally invasive ablation procedure offers long-term relief for patients who experience chronic and debilitating pain after knee replacement surgery, according to a study being presented next week at the annual meeting of the Radiological Society of North America.

24 Nov 2021

Limited immune responses three months after Pfizer-BioNTech vaccination among elderly

In this study, published on the medRxiv* preprint server, the humoral response to SARS-CoV-2 was assessed before and after three months of administration of the BNT162b2 mRNA COVID-19 vaccination (Pfizer-BioNTech). In addition, elders' humoral responses were compared to those of a younger group, and a functional neutralization experiment against the Wuhan-Hu-1 (WH1) virus and the Delta variant was carried out.

23 Nov 2021

People taking immunosuppressant produce weaker, shorter-lived antibodies after COVID-19 vaccination

People who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors -; a class of immunosuppressants used to treat rheumatoid arthritis and other autoimmune conditions -; generated less powerful and shorter-lived antibodies against the virus that causes COVID-19 than healthy people and those on other kinds of immunosuppressants, according to a study by researchers at Washington University School of Medicine in St. Louis.

21 Nov 2021

Repurposed ALS drug could slow gradual brain cell loss in Niemann-Pick disease type C1

Riluzole, a drug approved to treat amyotrophic lateral sclerosis (ALS), a disease affecting nerve cells controlling movement, could slow the gradual loss of a particular brain cell that occurs in Niemann-Pick disease type C1 (NPC1), a rare genetic disorder affecting children and adolescents, suggests a study in mice by scientists at the National Institutes of Health.

20 Nov 2021

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Moving more often is beneficial for long-term weight maintenance in older adults

A new approach for drugs to be more effective against inflammatory bowel disease

Trial identifies a drug that may benefit some patients hospitalized with COVID-19 pneumonia

‘The charges seem crazy’: Hospitals impose a ‘facility fee’ — for a video visit

Combination of gallic acid and stretching decreases arthritis inflammation markers in the cells

Colorado hospitals in ‘critical condition’ as state weathers another surge

New drug combination may prevent GvHD after stem cell transplantation for blood cancers

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Insight into immune cell communication may pave the way for new cancer vaccines

New report provides data on the wellbeing of working-age Australians with chronic conditions

Study identifies several proteins that protect against disease development

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

NEI researchers identify unique population of B cells that tamps down the immune system

Researchers identify new drug that makes pancreatic cancer cells more vulnerable to chemotherapy

Virginia Tech researchers discover potential target for diagnosing and treating Lyme disease

Irregular body clock plays key role in driving inflammation in the immune cells, research shows

Minimally invasive ablation procedure offers long-term relief after knee replacement surgery

Limited immune responses three months after Pfizer-BioNTech vaccination among elderly

People taking immunosuppressant produce weaker, shorter-lived antibodies after COVID-19 vaccination

Repurposed ALS drug could slow gradual brain cell loss in Niemann-Pick disease type C1

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in